Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 174,559 | 159,229 | 187,675 | 169,019 | 165,975 |
| Marketable Securities | N/A | 0 | 284,255 | 285,085 | 256,923 |
| Receivables | 265,012 | 259,865 | 234,597 | 228,159 | 240,262 |
| Inventories | 176,487 | 179,039 | 164,318 | 176,749 | 169,693 |
| Other current assets | 123,774 | 103,574 | 101,140 | 83,710 | 85,805 |
| TOTAL | $739,832 | $701,707 | $971,985 | $942,722 | $918,658 |
| Non-Current Assets | |||||
| PPE Net | 394,021 | 384,246 | 379,096 | 367,513 | 364,779 |
| Intangibles | 39,036 | 41,893 | 243,719 | 45,251 | 242,759 |
| Other Non-Current Assets | 347,796 | 341,646 | 118,616 | 313,848 | 110,941 |
| TOTAL | $780,853 | $767,785 | $741,431 | $726,612 | $718,479 |
| Total Assets | $1,520,685 | $1,469,492 | $1,713,416 | $1,669,334 | $1,637,137 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 68,015 | 70,409 | 66,968 | 60,583 | 58,606 |
| Accrued Expenses | 228,380 | 210,384 | 253,418 | 220,507 | 210,181 |
| TOTAL | $774,316 | $728,838 | $1,004,567 | $996,543 | $1,001,493 |
| Non-Current Liabilities | |||||
| Long Term Debt | 603,130 | 609,005 | 606,075 | 604,149 | 600,891 |
| Deferred Revenues | 40,921 | 40,545 | 29,181 | 29,203 | 28,706 |
| Other Non-Current Liabilities | 83,278 | 84,548 | 95,685 | 49,580 | 49,180 |
| TOTAL | $787,218 | $789,636 | $762,691 | $721,182 | $721,751 |
| Total Liabilities | $1,561,534 | $1,518,474 | $1,767,258 | $1,717,725 | $1,723,244 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,591 | 86,863 | 87,123 | 87,219 | 87,276 |
| Common Shares | 10,485 | 10,468 | 10,428 | 10,412 | 10,395 |
| Retained earnings | 989,039 | 880,348 | 803,545 | 765,288 | 694,777 |
| Other shareholders' equity | -37,530 | -27,957 | -29,746 | -28,780 | -31,752 |
| TOTAL | $-40,849 | $-48,982 | $-53,842 | $-48,391 | $-86,107 |
| Total Liabilities And Equity | $1,520,685 | $1,469,492 | $1,713,416 | $1,669,334 | $1,637,137 |